KQED's Forum As Final AIDS LifeCycle Ride Ends, Where Does AIDS Research Stand?
Jun 5, 2025
Jeff Sheehy, a long-time AIDS activist and first openly HIV+ member of the SF Board of Supervisors, joins infectious disease expert Monica Gandhi from UCSF and Jennifer Kates of KFF. They discuss the evolution of HIV treatment from a death sentence to manageable conditions. The guests reflect on historical activism, examine the impact of funding cuts on AIDS research, and emphasize the need for continued advocacy and community support. Personal stories highlight the resilience of communities and the ongoing fight against stigma.
AI Snips
Chapters
Transcript
Episode notes
San Francisco's Unique Community Unity
- In San Francisco, AIDS sparked a unique community response uniting the entire city including political leaders.
- This collective fight against the epidemic was a defining and proud moment for the city.
Activism Accelerated HIV Advances
- HIV activism pioneered the partnership among community, clinicians, and researchers driving rapid medical advances.
- This collaboration model has impacted other health fields and fast-tracked HIV medication development.
Integrating HIV and Drug Detox Care
- Barry from San Francisco shares his story of integrating HIV care with drug detox services and securing grants for clinics.
- His outreach improved testing and care access among IV drug users in the community.